1. Successful treatment of primary cardiac lymphoma with atrioventricular nodal block.
- Author
-
Takenaka S, Mitsudo K, Inoue K, Goto T, Kadota K, Fujii S, Yamamoto H, Fuku Y, Hirono A, Tanaka H, Taba M, Ikeda A, Kojima Y, Maekawa J, Maekawa S, Takahashi N, Saeki H, Nakamura Y, Oonishi T, and Ueda N
- Subjects
- Aged, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Cyclophosphamide administration & dosage, Doxorubicin administration & dosage, Drug Administration Schedule, Female, Heart Block therapy, Heart Neoplasms etiology, Humans, Lymphoma, B-Cell etiology, Lymphoma, Large B-Cell, Diffuse etiology, Pacemaker, Artificial, Prednisolone administration & dosage, Vincristine administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Heart Block complications, Heart Neoplasms drug therapy, Lymphoma, B-Cell drug therapy, Lymphoma, Large B-Cell, Diffuse drug therapy
- Abstract
A 69-year-old female suffering from third-degree atrioventricular block with syncope underwent permanent pacemaker implantation. However, she developed shortness of breath 2 months after the implantation. Blood tests revealed elevated levels of LDH, CRP, BNP, and SIL-2R. Transthoracic echocardiography showed thickened left and right atrial walls with mild pericardial effusion. A diagnosis was made based on a CT scan and histology. Although most primary cardiac malignant lymphomas are associated with a poor prognosis, the patient was treated successfully with chemotherapy.
- Published
- 2005
- Full Text
- View/download PDF